Skip to content

Clinical trials

Recruiting Alzheimer Disease trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Recruiting Country / region: Canada Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20091
20161
20171
20181
20191
20212
20223
20236
20245
202518
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting46

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sunnybrook Health Sciences Centre6
Bristol-Myers Squibb4
University Health Network, Toronto3
Washington University School of Medicine3
Alnylam Pharmaceuticals2
Baycrest2
Hoffmann-La Roche2
McGill University2
Rotman Research Institute at Baycrest2
University of Calgary2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease46
Dementia17
Cognitive Dysfunction12
Lewy Body Disease4
Frontotemporal Dementia3
Neurocognitive Disorders3
Brain Diseases2
Central Nervous System Diseases2
Dementia, Vascular2
Lethargy2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.